Test Price
2,800 AED✅ Home Collection Available
AARS2 Gene Leukoencephalopathy with Ovarian Failure Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed physician.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The AARS2 Gene Genetic Test is a conclusive molecular diagnostic designed to detect pathogenic variants in the AARS2 gene, which cause progressive leukoencephalopathy with ovarian failure—a rare neurometabolic disorder. This test empowers neurologists, gynecologists, and clinical geneticists in the UAE with definitive data for accurate diagnosis, family planning, and targeted management.
| Feature | Our Test (AARS2 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage incl. intronic regions | Sanger Sequencing – exonic regions only |
| Diagnostic Sensitivity | >99.9% | ~95% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Not guaranteed |
Physician Insight & Safety Protocols
Clinical Note from Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA: 9294403): “This NGS-based test provides definitive molecular confirmation for AARS2-related leukoencephalopathy. However, results must always be interpreted in the context of clinical findings and neuroimaging. A negative result does not exclude other genetic leukoencephalopathies, and I strongly recommend comprehensive genetic counseling to discuss reproductive options and cascade family screening.”
⚠️ Medication Advisory
Do not stop any prescribed medication without your doctor’s advice. Inform the phlebotomist about anticoagulant or antiplatelet therapy to reduce hematoma risk during the home visit.
Patient Safety & Exclusion Criteria
- Exclusion criteria: Blood draw within 4 weeks of transfusion, active severe infection, chemotherapy within the last 2 weeks, or inability to provide informed consent.
- Emergency red flags: Sudden vision loss, intractable seizures, altered consciousness, or severe unsteady gait – go to the nearest emergency department immediately, do not wait for test results.
Patient FAQ & Clinical Guidance
1. What does the AARS2 gene test diagnose?
This NGS test identifies AARS2 mutations causing progressive leukoencephalopathy with ovarian failure and neurological issues. It is the gold standard for confirming the genetic cause when clinical MRI shows white matter changes and ovarian insufficiency is present.
2. How should I prepare for the blood collection?
No fasting is required; simply ensure you are well hydrated and disclose all current medications. Our VIP phlebotomy team will schedule a home visit between 8 AM and 11 PM at your convenience.
3. How will I receive and interpret my results?
You will receive a secure, encrypted PDF report with detailed interpretation and clinical recommendations. A post‑test telephonic consultation with Dr. Quteineh is included to explain findings and next steps.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is stored on secure, UAE‑based servers and processed under DHA facility license 1143.
Clinical & Logistical Metadata
| Test Name | AARS2 Gene Leukoencephalopathy with Ovarian Failure Genetic Test (NGS) |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene coverage |
| ICD-10-CM Code | G93.8 |
| LOINC Code | 81323-7 |
| DHA Facility License & Laboratory Address | DHA License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians